Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer.

Wan, Guoxing; Cao, Fengjun; Wang, Xuanbin; Sun, Xue

Wan, Guoxing; Cao, Fengjun; Wang, Xuanbin; Sun, Xue.

Afiliação

Wan G; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.
Cao F; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.
Wang X; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.
Sun X; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.

J Cancer ; 10(2): 416-417, 2019.

Article em En | MEDLINE | ID: mdl-30719135

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google